Lepu Biopharma Co., Ltd.

14
Strong Sell
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100004SM4
HKD
4.58
0.1 (2.23%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Lepu Biopharma Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-23.00
-442.00
-131.00
-775.00
-1,218.00
-675.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-100.00
95.00
12.00
33.00
132.00
-77.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-42.00
-242.00
-308.00
-582.00
-758.00
-483.00
Cash Flow from Investing Activities
-166.00
-115.00
20.00
-86.00
-4.00
-827.00
Cash Flow from Financing Activities
691.00
329.00
19.00
1,223.00
467.00
1,551.00
Net Cash Inflow / Outflow
489.00
-26.00
-268.00
597.00
-298.00
240.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
7.00
1.00
0.00
44.00
-2.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Lepu Biopharma Co., Ltd.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Profit Before Tax
-23.0927561327969
1345.22124683278
-1,368.00
-101.72%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-100.915984169111
-99.5592145523496
-1.00
-1.36%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-42.9297731066844
1551.72548255096
-1,593.00
-102.77%
Cash Flow from Investing Activities
-166.103430413136
562.981009616293
-728.00
-129.50%
Cash Flow from Financing Activities
691.313154816577
-1971.84461609949
2,662.00
135.06%
Net Cash Inflow / Outflow
489.926925583722
151.784734895391
338.00
222.78%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
7.64697428696523
8.92285882762542
-1.00
-14.30%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 82.28% vs 21.58% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-42.93
-242.25
82.28%